BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36673031)

  • 1. THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer.
    Flockerzi FA; Hohneck J; Saar M; Bohle RM; Stahl PR
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis.
    Flockerzi FA; Hohneck J; Saar M; Bohle RM; Stahl PR
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and FGFR1-Wildtype in Female Patients with Squamous Cell Carcinoma of the Lung.
    Flockerzi FA; Hohneck J; Langer F; Bohle RM; Stahl PR
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble THSD7A is an N-glycoprotein that promotes endothelial cell migration and tube formation in angiogenesis.
    Kuo MW; Wang CH; Wu HC; Chang SJ; Chuang YJ
    PLoS One; 2011; 6(12):e29000. PubMed ID: 22194972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THSD7A expression in human cancer.
    Stahl PR; Hoxha E; Wiech T; Schröder C; Simon R; Stahl RA
    Genes Chromosomes Cancer; 2017 Apr; 56(4):314-327. PubMed ID: 28035718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of THSD7A in neoplasm tissues and its relationship with proteinuria.
    Xian L; Dong D; Luo J; Zhuo L; Li K; Zhang P; Wang W; Xu Y; Xu G; Wang L; Li G
    BMC Nephrol; 2019 Aug; 20(1):332. PubMed ID: 31443644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
    Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
    JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of Indian Patients With Membranous Nephropathy.
    Subramanian P; Kumar H; Tiwari B; Barwad A; Bagchi S; Bagga A; Agarwal SK; Dinda AK; Singh G
    Kidney Int Rep; 2020 Sep; 5(9):1551-1557. PubMed ID: 32954080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
    Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
    BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells.
    Rentala S; Chintala R; Guda M; Chintala M; Komarraju AL; Mangamoori LN
    Biochem Biophys Res Commun; 2013 Nov; 441(3):586-92. PubMed ID: 24177008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, prognosis and functional role of Thsd7a in esophageal squamous cell carcinoma of Kazakh patients, Xinjiang.
    Hou Z; Abudureheman A; Wang L; Hasim A; Ainiwaer J; Zhang H; Niyaz M; Upur H; Sheyhidin I
    Oncotarget; 2017 Sep; 8(36):60539-60557. PubMed ID: 28947992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy.
    Aktepe OH; Gundogdu F; Kosemehmetoglu K; Yeter HH; Aksoy S; Guven DC; Sahin TK; Yuce D; Kertmen N; Dizdar O; Yalcin S; Erman M
    Ir J Med Sci; 2022 Aug; 191(4):1561-1567. PubMed ID: 34472040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of deleted in liver cancer 1 and phosphorelated focal adhesion kinase in breast cancer].
    Feng Y; Zhou HX; Li JH; Li ZY; Cheng WG; Jin ML; He L
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1448-51. PubMed ID: 21868344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients.
    Chen Y; Xia X; Wang S; Wu X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Røe OD; Zhou J
    J Gastroenterol; 2013 Sep; 48(9):1034-44. PubMed ID: 23307041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer.
    Alexopoulou AN; Ho-Yen CM; Papalazarou V; Elia G; Jones JL; Hodivala-Dilke K
    BMC Cancer; 2014 Apr; 14():237. PubMed ID: 24693876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.
    Kaya B; Paydas S; Balal M; Eren Erdogan K; Gonlusen G
    Int J Clin Pract; 2021 Apr; 75(4):e13855. PubMed ID: 33249733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
    Rovin JD; Frierson HF; Ledinh W; Parsons JT; Adams RB
    Prostate; 2002 Oct; 53(2):124-32. PubMed ID: 12242727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
    Šelemetjev S; Bartolome A; Išić Denčić T; Đorić I; Paunović I; Tatić S; Cvejić D
    Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
    Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
    Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
    Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.